B7-33 (Relaxin-2 B-Chain Mimetic Peptide)

B7-33 is an experimental single-chain peptide designed from the B-chain of human Relaxin-2. Unlike the two-chain structure of native Relaxin-2, B7-33 uses a simplified peptide architecture to investigate relaxin-associated receptor signaling and downstream biological mechanisms.

One of the principal research targets associated with B7-33 is RXFP1 (Relaxin Family Peptide Receptor 1), a G protein-coupled receptor involved in multiple cellular signaling pathways associated with Relaxin-2.

In life science research, B7-33 is investigated in connection with RXFP1 receptor signaling, extracellular matrix (ECM) regulation, collagen-related processes, fibroblast biology, fibrosis-related mechanisms, and tissue remodeling.

Preclinical research has also explored B7-33 in cardiovascular, renal, and other tissue fibrosis models, making it a useful experimental tool for studying relationships between Relaxin/RXFP1 signaling, extracellular matrix remodeling, and tissue biology.

B7-33 remains an experimental research peptide, and findings from laboratory or preclinical studies should not be interpreted as established anti-fibrotic, cardioprotective, or other therapeutic effects in humans.

La livraison est facturée selon le nombre d'articles de la commande, aux mêmes tarifs pour toutes les destinations, et le montant exact s'affiche au moment du paiement, avant de payer. Expédition sous 1 jour ouvré.

Pas convaincu ? Renvoyez le produit sous 30 jours pour un remboursement intégral, même ouvert.